SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon reply to clarification sought by the exchange

24 Aug 2015 Evaluate

With reference to the news item appearing on Business Standard on August 22, 2015 titled ‘USFDA observations’, Biocon has clarified that USFDA conducts audit at regular intervals. Biocon underwent such inspection in June 2015, wherein a few minor observations in the nature of recommendations were made by the regulatory team. All those have been considered by the Company and closed out with the FDA. None of the USFDA observations were material in nature to have bearing on operation / performance of the Company or price sensitive in nature.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

357.65 -3.75 (-1.04%)
22-Apr-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.00
Dr. Reddys Lab 1220.65
Cipla 1234.55
Zydus Lifesciences 930.80
Lupin 2304.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×